Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol and isosorbide mononitrate for lacunar stroke small vessel disease
2015-001953-33Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cilostazol and isosorbide mononitrate in lacunar infarct and Cerebral Small Vessel Disease (CSVD) (4 arms), sponsored by University of Edinburgh. Started Aug 2015; status: completed.
02
Drugs
cilostazolisosorbide mononitrate
03
Conditions
lacunar infarctCerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on 2015-001953-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001953-33.